Therefore, the proposed analysis of the genetic status may facilitate the identification of mutations in the SMAD4 gene as a novel diagnostic marker or therapeutic target in HNSCC and other head and neck cancers. The gene discussed is SMAD4; the disease is head and neck squamous cell carcinoma.